In this free webinar, explore approaches to developing and implementing proliferation, AAV/mRNA potency, cell killing and flow cytometry assays in...
Bevacizumab is a targeted therapy used to treat lung and colorectal cancers, both among the top three cancers ranked by...
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and...
BOULDER, Colo., Oct. 27, 2025 /PRNewswire/ -- Integral Consulting Inc. (Integral) announces a strategic partnership with Verdi Technology Inc. (VTI) to...
WOODSTOCK, Ga., Oct. 27, 2025 /PRNewswire/ -- Kragor Orthodontics, a leading orthodontic practice serving Woodstock, Canton, and surrounding Georgia communities,...
EXTON, Pa., Oct. 27, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug...
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Immunoglobulin G4-Related Disease ORLANDO, FLORIDA / ACCESS...
Executive leadership expansion in long-term care pharmacy technology reflects the growing demand driven by America's aging population and rising senior...
Company advances digital technology initiatives with approval to publish applications on the Google Play Store. MESA, ARIZONA / ACCESS Newswire...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical...
NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell...
NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical...
NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of...
Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to deliver a large...
Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to deliver a large...